ContactDictionary

Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Appendix carcinoma
Results 1-21 of 21 for your search:
Start Over
Surgery or Non-surgical Management in Treating Patients with Intra-abdominal Cancer and Bowel Obstruction
Status: Active
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: S1316, NCI-2014-01497, SWOG/S1316, NCT02270450
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Status: Active
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201404101, NCI-2013-00650, NCT01790035
Mitomycin C or Floxuridine and Leucovorin Calcium during or after Surgery in Treating Patients with Appendiceal, Colon, or Rectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-289, NCI-2013-00818, NCT01815359
Dendritic Cell Vaccine, Recombinant Interferon Alfa, Rintatolimod, and Celecoxib After Surgery in Treating Patients with Peritoneal Surface Cancers
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 12-110, NCI-2014-01357, 02151448, NCT02151448
Postoperative Chemotherapy in Treating Patients with High-Grade Appendiceal Cancer with Peritoneal Carcinomatosis
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 18
Trial IDs: 150295, NCI-2015-02042, NCT02420509
Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin C Followed by Standard Chemotherapy in Treating Patients with Peritoneal Carcinomatosis
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-09-332, NCI-2013-01214, 11-075, NCT02040142
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
Biweekly Intraperitoneal Oxaliplatin with Systemic Capecitabine and Bevacizumab for Patients with Peritoneal Carcinomatosis from Appendiceal or Colorectal Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 10-0136 / 201107017, NCI-2011-01043, 10-0136, NCT01061515
Ph 1 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced Gastrointestinal Malignancies
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: POLARIS2013-001, NCI-2017-00851, NCT02102022
CD8+ T Cell Therapy and Pembrolizumab in Treating Patients with Metastatic Gastrointestinal Tumors
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0152, NCI-2016-01058, NCT02757391
GL-ONC1 with or without Eculizumab in Treating Patients with Solid Organ Cancers before Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GL-ONC1-011, NCI-2016-01782, NCT02714374
Collection of Tissue Samples in Identifying Novel Therapeutic Targets in Patients with Solid Tumors Undergoing Surgery or Biopsy
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology, Tissue collection/Repository
Age: 16 and over
Trial IDs: 12-C-0175, NCI-2015-01248, 320831, P121006, NCT01658917
Combination Chemotherapy in Treating Patients with Metastatic Appendiceal Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 2012-1050, NCI-2015-00850, NCT01946854
Natural History Study of Cancer Susceptibility in Patients with Fanconi Anemia, Inherited Bone Marrow Failure Syndromes, and Family Members
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: Not specified
Trial IDs: 02-C-0052, NCI-2013-02026, CGB 7130, NCT00056121, NCT00027274
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors
Status: Active
Phase: No phase specified
Type: Health services research, Supportive care
Age: 18 to 39
Trial IDs: 9161, NCI-2014-01325, NCT02192333
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients with Gastrointestinal or Breast Malignancies
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: 2014-0250, NCI-2015-00386, NCT02221700
Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients with Cancer Undergoing Surgery
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 60 to 90
Trial IDs: CCCWFU 02114, NCI-2015-00097, NCT02356471
Assessing Quality of Life in Patients with Refractory Malignant Ascites Undergoing Peritoneal-Venous Shunt
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: UPCC 26813, NCI-2015-01009, 819053, NCT02477657
Creative Writing Intervention in Improving the Psychological Effect of Cancer in Patients with Advanced Lung or Gastrointestinal Cancer
Status: Active
Phase: No phase specified
Type: Supportive care
Age: Not specified
Trial IDs: D15113, NCI-2016-00373, NCT02575898
Electronic Activity Monitoring in Assessing Functional Activity in Patients with Gastrointestinal Cancer Undergoing Chemotherapy
Status: Active
Phase: No phase specified
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: 16-493, NCI-2016-01608, NCT02909062
PRIME in Improving Overall Care in Older Patients with Breast, Gastrointestinal, or Lung Cancer
Status: Active
Phase: No phase specified
Type: Supportive care
Age: 65 and over
Trial IDs: 16-230, NCI-2016-01765, NCT02871115
Start Over